Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its ...

Real-time index price for S&P 500 ESG (ESG), along with buy or sell indicators, analysis, charts, historical performance, ...

Q1 was way below expectations, and the outlook has been diminished. The stock looks expensive to peers. Find out why TLRY ...

This randomized, placebo-controlled trial aimed to test the effectiveness of an oral cannabis extract in adults suffering from CINV despite standard anti-nausea treatments. Participants received ...

The market promised tremendous growth potential. Major players such as Canopy Growth (CGC), Aurora Cannabis (ACB), and Aphria (now part of Tilray Brands) quickly established themselves as industry ...

Leamington, Ontario-based cannabis producer Tilray reported earnings for the quarter and fiscal year ended May 31, with net revenue growing 22% to $628 million, up from $513 million in fiscal 2021.

OFF THE RECORD: Four cameras on the coast guard vessel were removed in 2022 amid a campaign to phase out the use of Chinese products, an investigation found ...

Tilray's Q1 revenue missed estimates by $21 million, showing 13% year-over-year growth driven by beverage acquisitions, while cannabis revenue declined nearly 13%. The company reported a larger ...

It's time for your guide to today's Wordle answer, featuring my commentary on the latest puzzle, plus a selection of hints designed to help you keep your streak going. Don't think you need any ...

Nov. 11, 2024 — Why is the expansion of our Universe accelerating? Twenty-five years after its discovery, this phenomenon remains one of the greatest scientific mysteries. Solving it involves ...